Exact Sciences CEO on the Cologuard maker's surge in revenue and users

Exact Sciences CEO Kevin Conroy recaps his comapany's quarterly results with CNBC's Meg Tirrell, discussing his growth strategy, Exact Sciences' new partnership with Pfizer, and the company's flagship at-home test for colon cancer.
Fri, Nov 2 20184:50 PM EDT